Search research articles
Contact Us
Filters
Showing results (761-770 of 891) with videos related to
Page
of 90
Sort By:
Cancer Letters
|
January 18, 2018
Corrigendum on "Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer" [Cancer Lett. 363 (1) (2015) 28-36]
Kanjoormana A Manu, Muthu K Shanmugam, Lalitha Ramachandran, et al.
British Journal of Pharmacology
|
July 16, 2013
Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3
Aruljothi Subramaniam, Muthu K Shanmugam, Tina H Ong, et al.
International Journal of Biological Macromolecules
|
February 24, 2022
Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Yalda Saghari, et al.
Cancer Letters
|
April 2, 2015
Isorhamnetin augments the anti-tumor effect of capecitabine through the negative regulation of NF-κB signaling cascade in gastric cancer
Kanjoormana A Manu, Muthu K Shanmugam, Lalitha Ramachandran, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 20, 2026
Retraction notice to "New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities" [Biomedicine & Pharmacotherapy 141 (2021) 111824]
Milad Ashrafizadeh, Sepideh Mirzaei, Farid Hashemi, et al.
Journal of Psychiatric Research
|
January 26, 2021
Mindfulness intervention for mild cognitive impairment led to attention-related improvements and neuroplastic changes: Results from a 9-month randomized control trial
Junhong Yu, Iris Rawtaer, Lei Feng, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition
|
July 13, 2019
Screening for early onset neonatal sepsis: NICE guidance-based practice versus projected application of the Kaiser Permanente sepsis risk calculator in the UK population
Nitin Goel, Sudeep Shrestha, Rhian Smith, et al.
International Journal of Molecular Sciences
|
December 15, 2019
Pharmacological Inhibition of TFF3 Enhances Sensitivity of CMS4 Colorectal Carcinoma to 5-Fluorouracil through Inhibition of p44/42 MAPK
Ru-Mei Chen, Yi-Shiou Chiou, Qing-Yun Chong, et al.
Oncotarget
|
July 9, 2016
Gelsolin-Cu/ZnSOD interaction alters intracellular reactive oxygen species levels to promote cancer cell invasion
Lalchhandami Tochhawng, Shuo Deng, Ganesan Pugalenthi, et al.
Plos One
|
May 19, 2025
Design, synthesis and in silico molecular modelling studies of 2-Hydrazineyl-2-oxoethyl-4-(1H-pyrrol-1-yb) benzoate derivatives: a potent dual DHFR and ENR-reductase inhibitors with antitubercular, antibacterial and cytotoxic potential
Mater H Mahnashi, Prem Kumar Santhemavathuru Ramachandraiah, Ahmed Abdullah Al Awadh, et al.
Page
of 90
Search research articles
Search
Showing results (761-770 of 891) with videos related to
Sort By:
Page
of 90
Cancer Letters
|
January 18, 2018
Corrigendum on "Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer" [Cancer Lett. 363 (1) (2015) 28-36]
Kanjoormana A Manu, Muthu K Shanmugam, Lalitha Ramachandran, et al.
British Journal of Pharmacology
|
July 16, 2013
Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3
Aruljothi Subramaniam, Muthu K Shanmugam, Tina H Ong, et al.
International Journal of Biological Macromolecules
|
February 24, 2022
Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Yalda Saghari, et al.
Cancer Letters
|
April 2, 2015
Isorhamnetin augments the anti-tumor effect of capecitabine through the negative regulation of NF-κB signaling cascade in gastric cancer
Kanjoormana A Manu, Muthu K Shanmugam, Lalitha Ramachandran, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 20, 2026
Retraction notice to "New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities" [Biomedicine & Pharmacotherapy 141 (2021) 111824]
Milad Ashrafizadeh, Sepideh Mirzaei, Farid Hashemi, et al.
Journal of Psychiatric Research
|
January 26, 2021
Mindfulness intervention for mild cognitive impairment led to attention-related improvements and neuroplastic changes: Results from a 9-month randomized control trial
Junhong Yu, Iris Rawtaer, Lei Feng, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition
|
July 13, 2019
Screening for early onset neonatal sepsis: NICE guidance-based practice versus projected application of the Kaiser Permanente sepsis risk calculator in the UK population
Nitin Goel, Sudeep Shrestha, Rhian Smith, et al.
International Journal of Molecular Sciences
|
December 15, 2019
Pharmacological Inhibition of TFF3 Enhances Sensitivity of CMS4 Colorectal Carcinoma to 5-Fluorouracil through Inhibition of p44/42 MAPK
Ru-Mei Chen, Yi-Shiou Chiou, Qing-Yun Chong, et al.
Oncotarget
|
July 9, 2016
Gelsolin-Cu/ZnSOD interaction alters intracellular reactive oxygen species levels to promote cancer cell invasion
Lalchhandami Tochhawng, Shuo Deng, Ganesan Pugalenthi, et al.
Plos One
|
May 19, 2025
Design, synthesis and in silico molecular modelling studies of 2-Hydrazineyl-2-oxoethyl-4-(1H-pyrrol-1-yb) benzoate derivatives: a potent dual DHFR and ENR-reductase inhibitors with antitubercular, antibacterial and cytotoxic potential
Mater H Mahnashi, Prem Kumar Santhemavathuru Ramachandraiah, Ahmed Abdullah Al Awadh, et al.
Page
of 90